UiPath delivered a beat-and-raise quarter and was promoted into a midcap index. Shares of automation software company UiPath ...

Once thought to be doomed by the AI revolution, robotic process automation specialist UiPath ( PATH +2.94%) defied critics in ...

UiPath hits an inflection point with stabilizing SaaS, AI roadmap, Maestro platform upsells, top partnerships, and clean ...

UiPath Inc. (NYSE:PATH) is one of the most buzzing stocks to invest in according to hedge funds. On January 5, RBC Capital ...

In early January 2026, UiPath Inc. was added to the S&P 1000 and S&P MidCap 400 indices after reporting earnings that ...

What Happened? Shares of automation software company UiPath (NYSE:PATH) fell 5% in the morning session after a broader market ...

UiPath Inc. (NYSE:PATH) provides an end-to-end automation platform that offers a range of robotic process automation/RPA ...

Model Context Protocol-based agentic integration allows for faster, more accurate access and usage of data and information to reduce errors and elevate productivity ...

Recently, Zacks.com users have been paying close attention to UiPath (PATH). This makes it worthwhile to examine what the stock has in store.

UiPath aims to lead the RPA market by integrating advanced AI solutions, differentiating itself from competitors like Automation Anywhere and Blue Prism. Strategic partnerships with tech giants like ...

Testing an AI agent for donor tissue screening at Evergen surfaces more than technical performance questions. The project ...

Learn more about whether Adeia Inc. or UiPath Inc. is a better investment based on AAII's A+ Investor grades, which compare ...